Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Trivic, Vladimir (36996311900)"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    WUNDERLICH’S SYNDROME IN COVID-19 PATIENT
    (2023)
    Opancina, Miljan (57192909391)
    ;
    Mijailovic, Zeljko (6506982098)
    ;
    Vojinovic, Radisa (11640450400)
    ;
    Saponjski, Jovica (56629875900)
    ;
    Trivic, Vladimir (36996311900)
    ;
    Opancina, Valentina (57192906143)
    Up to this date, more than 180 million people worldwide have been affected with COVID-19 and more than 3.9 million people have died. The effect of COVID-19 on thrombosis is well known, and due to this, anticoagulant agents are prescribed. However, the use of anticoagulants is associated with the bleeding trend and occasionally major complications and death outcomes. In this paper, we present the case of a COVID-19 patient treated with anticoagulant therapy who developed Wunderlich’s syndrome. Up to our knowledge, this is the first case of this syndrome in a patient with COVID-19. © Experimental and Applied Biomedical Research.All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    WUNDERLICH’S SYNDROME IN COVID-19 PATIENT
    (2023)
    Opancina, Miljan (57192909391)
    ;
    Mijailovic, Zeljko (6506982098)
    ;
    Vojinovic, Radisa (11640450400)
    ;
    Saponjski, Jovica (56629875900)
    ;
    Trivic, Vladimir (36996311900)
    ;
    Opancina, Valentina (57192906143)
    Up to this date, more than 180 million people worldwide have been affected with COVID-19 and more than 3.9 million people have died. The effect of COVID-19 on thrombosis is well known, and due to this, anticoagulant agents are prescribed. However, the use of anticoagulants is associated with the bleeding trend and occasionally major complications and death outcomes. In this paper, we present the case of a COVID-19 patient treated with anticoagulant therapy who developed Wunderlich’s syndrome. Up to our knowledge, this is the first case of this syndrome in a patient with COVID-19. © Experimental and Applied Biomedical Research.All rights reserved.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback